Overview
This activity is designed to meet the educational needs of members of the multidisciplinary CLL care team: Oncologists/heme oncologists, oncology APPs (NPs, pharmacists, PAs), oncology nurses, oncology navigators, oncology clinical social workers, and other members of the cancer care team who are involved with care for patients with CLL.
This course is brought to you in partnership with our sister company freeCME. Clicking the Add to Cart button will take you to the freeCME website where you can access this course for FREE.
Goals and Learning Outcomes
Upon completion of this activity, participants should be better able to:
- Discuss new therapeutic options (with an emphasis on oral/oral combination therapies), including treatment initiation and management, lab monitoring, patient logistics, and how these new options may impact the patient experience
- Help providers garner a better understanding of patient preferences around fixed duration vs. treat-to-progression regimens
- Review best practices in shared decision making (SDM) around fixed duration vs. treat-to-progression and key issues to be discussed in the SDM process (eg, patient preferences, costs, travel/transportation)
- Discuss the benefits of being off CLL treatment when receiving covid vaccines (share data showing this potentially leads to stronger immune response/antibody formation/immune protection)
Faculty
Christine Helou, MSN, FNP-BC, OCN
Oncology Nurse Practitioner
Virginia Cancer Specialists
Fairfax, VA
Jose Sandoval Sus, MD, FACP
Hematologic Oncologist, Associate Member
Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Pembroke Pines, FL
Adam Kittai, MD
Associate Professor of Medicine
Assistant Director of Lymphoma Clinical Research
Mount Sinai
New York, NY
Jeff Sharman, MD
Medical Oncologist, Hematologist
Willamette Valley Cancer Institute
Eugene, OR
Course Details
FREECME2026-03-01
Accreditations
This course is being provided by a Relias LLC strategic partner. Consumption of this course will take place on the partners site and courses provided in this manner are not accredited by Relias LLC.